S1047 Improved IBD Clinical Outcomes Using Combination Therapy With Infliximab and Immunomodulator Compared to Monotherapy with Infliximab Alone: A Comprehensive Meta-Analysis

Saved in:
Bibliographic Details
Published inThe American journal of gastroenterology Vol. 118; no. 10S; pp. S795 - S796
Main Authors Lowell, Jeffrey, Sultan, Keith S.
Format Journal Article
LanguageEnglish
Published New York Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins 01.10.2023
Subjects
Combination therapy
Immunomodulators
Inflammatory bowel disease
Meta-analysis
Patients
Remission (Medicine)
Systematic review
Online AccessGet full text

Cover

More Information
ISSN:0002-9270
1572-0241
DOI:10.14309/01.ajg.0000953828.56264.be